Torrent Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on January 29, 2013, to consider and approve the audited financial results on standalone basis and unaudited financial results (with limited review) on consolidated basis of the company for the quarter and nine months ended on December 31, 2012 (Q3) and would also consider payment of interim dividend for the year 2012-13.
The above information is a part of company’s filings submitted to BSE